174 related articles for article (PubMed ID: 34974068)
1. A genomic approach identifies sRAGE as a putatively causal protein for asthma.
Bui H; Keshawarz A; Hwang SJ; Yao C; Lee GY; Recto K; O'Connor GT; Levy D
J Allergy Clin Immunol; 2022 Jun; 149(6):1992-1997.e12. PubMed ID: 34974068
[TBL] [Abstract][Full Text] [Related]
2. An Integrative Genomic Strategy Identifies sRAGE as a Causal and Protective Biomarker of Lung Function.
Keefe J; Yao C; Hwang SJ; Courchesne P; Lee GY; Dupuis J; Mizgerd JP; O'Connor G; Washko GR; Cho MH; Silverman EK; Levy D
Chest; 2022 Jan; 161(1):76-84. PubMed ID: 34237330
[TBL] [Abstract][Full Text] [Related]
3. Integrative Mendelian randomization reveals the soluble receptor for advanced glycation end products as protective in relation to rheumatoid arthritis.
Lee GY; Yao C; Hwang SJ; Ma J; Joehanes R; Lee DH; Ellison RC; Moore LL; Liu C; Levy D
Sci Rep; 2023 May; 13(1):8002. PubMed ID: 37198231
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.
Lim SC; Dorajoo R; Zhang X; Wang L; Ang SF; Tan CSH; Yeoh LY; Ng XW; Li N; Su C; Liu S; Wong MDS; Low KMS; Yao AO; Babitha J; Fun S; Zhou S; Lee SBM; Tang WE; Tavintharan S; Sum CF; Liu JJ
Nephrol Dial Transplant; 2017 Oct; 32(10):1697-1704. PubMed ID: 27448675
[TBL] [Abstract][Full Text] [Related]
5. Plasma sRAGE Acts as a Genetically Regulated Causal Intermediate in Sepsis-associated Acute Respiratory Distress Syndrome.
Jones TK; Feng R; Kerchberger VE; Reilly JP; Anderson BJ; Shashaty MGS; Wang F; Dunn TG; Riley TR; Abbott J; Ittner CAG; Christiani DC; Mikacenic C; Wurfel MM; Ware LB; Calfee CS; Matthay MA; Christie JD; Meyer NJ
Am J Respir Crit Care Med; 2020 Jan; 201(1):47-56. PubMed ID: 31487195
[No Abstract] [Full Text] [Related]
6. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.
Sin S; Lim MN; Kim J; Bak SH; Kim WJ
BMC Pulm Med; 2022 Feb; 22(1):58. PubMed ID: 35144588
[TBL] [Abstract][Full Text] [Related]
7. Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study.
Maruthur NM; Li M; Halushka MK; Astor BC; Pankow JS; Boerwinkle E; Coresh J; Selvin E; Kao WH
PLoS One; 2015; 10(6):e0128452. PubMed ID: 26083729
[TBL] [Abstract][Full Text] [Related]
8. Decreased soluble RAGE in neutrophilic asthma is correlated with disease severity and RAGE G82S variants.
Lyu Y; Zhao H; Ye Y; Liu L; Zhu S; Xia Y; Zou F; Cai S
Mol Med Rep; 2018 Mar; 17(3):4131-4137. PubMed ID: 29257350
[TBL] [Abstract][Full Text] [Related]
9. Epigenome-wide DNA methylation association study of circulating IgE levels identifies novel targets for asthma.
Recto K; Kachroo P; Huan T; Van Den Berg D; Lee GY; Bui H; Lee DH; Gereige J; Yao C; Hwang SJ; Joehanes R; Weiss ST; ; O'Connor GT; Levy D; DeMeo DL
EBioMedicine; 2023 Sep; 95():104758. PubMed ID: 37598461
[TBL] [Abstract][Full Text] [Related]
10. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
11. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
12. The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.
Miller S; Henry AP; Hodge E; Kheirallah AK; Billington CK; Rimington TL; Bhaker SK; Obeidat M; Melén E; Merid SK; Swan C; Gowland C; Nelson CP; Stewart CE; Bolton CE; Kilty I; Malarstig A; Parker SG; Moffatt MF; Wardlaw AJ; Hall IP; Sayers I
PLoS One; 2016; 11(10):e0164041. PubMed ID: 27755550
[TBL] [Abstract][Full Text] [Related]
13. Plasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.
Manichaikul A; Sun L; Borczuk AC; Onengut-Gumuscu S; Farber EA; Mathai SK; Zhang W; Raghu G; Kaufman JD; Hinckley-Stukovsky KD; Kawut SM; Jelic S; Liu W; Fingerlin TE; Schwartz DA; Sell JL; Rich SS; Barr RG; Lederer DJ
Ann Am Thorac Soc; 2017 May; 14(5):628-635. PubMed ID: 28248552
[TBL] [Abstract][Full Text] [Related]
14. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Cheng DT; Kim DK; Cockayne DA; Belousov A; Bitter H; Cho MH; Duvoix A; Edwards LD; Lomas DA; Miller BE; Reynaert N; Tal-Singer R; Wouters EF; Agustí A; Fabbri LM; Rames A; Visvanathan S; Rennard SI; Jones P; Parmar H; MacNee W; Wolff G; Silverman EK; Mayer RJ; Pillai SG;
Am J Respir Crit Care Med; 2013 Oct; 188(8):948-57. PubMed ID: 23947473
[TBL] [Abstract][Full Text] [Related]
15. Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
Loomis SJ; Chen Y; Sacks DB; Christenson ES; Christenson RH; Rebholz CM; Selvin E
Clin Chem; 2017 May; 63(5):980-989. PubMed ID: 28280052
[TBL] [Abstract][Full Text] [Related]
16. Soluble receptor for advanced glycation end products (sRAGE) and asthma: Mendelian randomisation study.
Raita Y; Zhu Z; Freishtat RJ; Fujiogi M; Liang L; Patregnani JT; Camargo CA; Hasegawa K
Pediatr Allergy Immunol; 2021 Jul; 32(5):1100-1103. PubMed ID: 33599351
[No Abstract] [Full Text] [Related]
17. Serum Soluble Receptor for Advanced Glycation End Products in Infants With Bronchiolitis: Associations With Acute Severity and Recurrent Wheeze.
Patregnani JT; Fujiogi M; Camargo CA; Brooks BA; Hoptay CE; Mansbach JM; Teach SJ; Freishtat RJ; Hasegawa K
Clin Infect Dis; 2021 Nov; 73(9):e2665-e2672. PubMed ID: 33173945
[TBL] [Abstract][Full Text] [Related]
18. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
19. Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.
Sharifi-Zahabi E; Sharafabad FH; Abdollahzad H; Malekahmadi M; Rad NB
Adv Nutr; 2021 Dec; 12(6):2157-2171. PubMed ID: 34139010
[TBL] [Abstract][Full Text] [Related]
20. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Horimasu Y; Ohshimo S; Fujitaka K; Hamada H; Mazur W; Kohno N; Hattori N
Respirology; 2017 Jul; 22(5):965-971. PubMed ID: 28198072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
